U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07113769) titled 'Plasma Biomarkers and Platelet Morphology of Extracorporeal CardioPulmonary Resuscitation' on June 18.
Brief Summary: Extracorporeal cardiopulmonary resuscitation (ECPR) constitutes a pivotal emergency intervention for cardiac arrest (CA) patients. However, current eligibility criteria and prognostic assessment metrics remain substantially limited, relying predominantly on clinical symptoms and physical signs while lacking objective biomarker data. Integrating reproducible, highly sensitive, and specific proteinaceous and metabolic indicators with ultrastructural platelet alterations may hold significant implications for both ECPR a...